As part of Sanofi’s Golden Ticket competition, Sanofi will award free lab bench space at Tufts Launchpad | BioLabs (75 Kneeland St, Boston, MA) to one promising startup company.

The two key focus areas for 2022 addressing therapeutic challenges in oncology, immuno-inflammation, neuroscience, rare diseases & vaccine are:

• Targeted or controlled delivery and conditional activation of biologics or genomic medicines to increase tissue specific exposure
• New and next generation genome editing technologies with breakthrough potential for in vivo therapeutics

All companies that are engaged in these fields are encouraged to apply.

The application period is now open. Applicants must complete an application and submit to GoldenTicket@sanofi.com by 11:59pm EST on February 11, 2022.  A sub-set of applicants will be selected as finalists and will be invited to present at the virtual Sanofi Golden Ticket pitch showcase on March 31, 2022.

For more information, visit: https://www.sanofi.com/en/science-and-innovation/partnering/golden-ticket-competition. If you have any questions, reach out to Danielle Bogdanowicz, Director, Tufts Launchpad BioLabs (dbogdanowicz@biolabs.io).

Sanofi and BioLabs

Sanofi is a Founding sponsor of BioLabs Hôtel-Dieu in Paris and a Gold sponsor of Tufts Launchpad BioLabs in Boston and BioLabs Heidelberg.